Navigation Links
Lyophilization Services of New England Completes FDA Inspection
Date:1/8/2014

MANCHESTER, N.H., Jan. 8, 2014 /PRNewswire/ -- Lyophilization Services of New England (LSNE), a New Hampshire based contract manufacturing organization is pleased to announce that the Food and Drug Administration (FDA) recently completed an inspection of their Manchester manufacturing facility.  This is the sixth successful inspection of the site, which is currently functioning as a multiproduct medical device manufacturing facility.  The November 2013 inspection was a combination FDA general GMP and Pre-approval inspection.  The inspection resulted in no Form 483 being issued, as there were no observations noted by FDA.

Matthew Halvorsen, President and Chief Executive Officer of LSNE stated, "We are very pleased with the result of the latest FDA inspection, which adds to our successful regulatory history.  LSNE is committed to maintaining the highest level of quality across our three manufacturing sites so that we can remain a reliable partner to our clients."

This FDA inspection follows a successful MHRA inspection of the LSNE 25 Commerce Drive, Bedford NH contract pharmaceutical manufacturing facility in which LSNE received a Certificate of GMP Compliance from the UK Medicines and Healthcare Products Regulatory Agency (MHRA) to manufacture aseptic lyophilized drug products for use in the European Union.

About LSNE Contract Manufacturing

LSNE Contract Manufacturing is a privately held company with three GMP facilities located in New England.   LSNE has been providing contract lyophilization services to the pharmaceutical, biotechnology and medical device industries since 1997, specializing in a wide range of services including cycle development, cGMP fill/finish, and lyophilization.  Through the thoughtful integration of three processing facilities, qualified staffing, and an extensive manufacturing history, LSNE is strategically positioned to provide uninterrupted manufacturing for clinical through commercial supply for medical device and pharmaceuticals to a multi-national market.

Media Contact
Christine Palus
Vice President of Sales & Marketing
(603) 668-5763
info@lyophilization.com
www.lyophilization.com


'/>"/>
SOURCE Lyophilization Services of New England
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. ANI Pharmaceuticals Enters Development Agreement for Generic Drug Product with Sterling Pharmaceutical Services
2. Improving the Quality and Effectiveness of Marketing Services Groups in an Environment Characterized by Globalization and Shrinking Resources
3. inviCRO hires Stefan Linehan as Director of Ex Vivo Research & Imaging Services
4. Clayton, Dubilier & Rice to Invest in PharMEDium, Nations Leading Provider of Sterile Compounding Services to Hospital Pharmacies
5. Smithers Quality Assessments Expands Certification Services to Include Pharmaceuticals Industry
6. Cord Blood Banking Services Market is Expected to Reach USD 15.2 Billion Globally in 2019: Transparency Market Research
7. Indegene launches a complete range of MCM services specifically focused on integrated brand-product promotions.
8. Genpact and AstraZeneca Extend Finance and Accounting Services Agreement
9. Liquidity Services Delivers Surplus Asset Solutions in Support of Hoffmann-La Roches Consolidation Initiative
10. Numotion Acquires the Custom Mobility Division of Barnes Healthcare Services
11. PBL Assay Science announces ultra-sensitive assay services to measure biomolecules in human serum or plasma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... , May 24, 2016 ... den Markt gebracht, die es Ärzten erlaubt, ihre ... zu behandeln: MDLinking kombiniert Live Streaming mit einer ... Umfeld zu kommunizieren. Mediziner in Europa, Afrika, Asien ... sich bereits für die Plattform registriert. ...
(Date:5/24/2016)... CHRISTCHURCH, New Zealand , May 24, 2016 ... scanning and informatics solutions for the healthcare sector, has been ... the New Zealand Hi-Tech Awards 2016. Dr ... a fantastic acknowledgement for our team.  It,s really good to ... the burden healthcare internationally. Our products are used in 35 ...
(Date:5/24/2016)... , May 24, 2016 ... de doble terapia del mundo, introduce catéteres para ... OrbusNeich, una compañía global especializada en ... vidas, ha expandido su cartera incluyendo productos para ... JADE™ y Scoreflex™ PTA son los dispositivos de ...
Breaking Medicine Technology:
(Date:5/24/2016)... ... May 24, 2016 , ... ... corporate identity and website at its “Transforming Outcomes” User Conference in Las Vegas ... reflect i2i’s ongoing success to set the market standard for meaningful population health ...
(Date:5/24/2016)... ... May 24, 2016 , ... ... of communication enabled solutions and managed services today announced a strategic partnership ... enterprise contact center market. , Altura, one of Avaya’s largest Platinum Business ...
(Date:5/24/2016)... Church, VA (PRWEB) , ... May 24, 2016 , ... ... 14-15, 2016 · Raleigh, NC, http://www.fdanews.com/humanerrordrugdevice , Human error is known to ... is unlikely that human error will ever be totally eliminated, many human performance problems ...
(Date:5/24/2016)... ... ... Regenerative Medicine is being transformed by ongoing research and clinical findings at ... results as have been achieved with Okyanos Cell Therapy are paving the ... patients worldwide. , As the Medical Advisory Chairman at Okyanos, Eric Duckers, MD, PhD, ...
(Date:5/24/2016)... ... May 24, 2016 , ... ... or injury that focuses on repairing the musculoskeletal and neuromuscular systems of the ... on functional restoration, NYDNRehab began providing treatments for physical therapy in New York, ...
Breaking Medicine News(10 mins):